<b>Backgroud and objectives:</b> Although lung attenuation distribution and lung volume on computed tomography (CT) have been widely used in evaluating COPD and interstitial lung disease, there are only a few studies regarding the normal range of these indices, especially in Chinese subjects.
<b>Conclusion:</b> 6MWD and EID exhibit different determinants in COPD with a minor impact of comorbidities limited to hypertension in EID and to obesity, which was unexpectedly associated with less EID.
<b>Conclusion:</b> 6MWD and EID exhibit different determinants in COPD with a minor impact of comorbidities limited to hypertension in EID and to obesity, which was unexpectedly associated with less EID.
<b>Conclusions:</b> This study suggests that patients with stable moderate-to-severe COPD show higher activation in emotion-related brain areas than healthy controls during the anticipation, but not during the actual perception of experimentally induced dyspnea.
<b>Introduction</b>: Neutrophils are the most abundant inflammatory cells in the lungs of patients with chronic lung diseases, especially COPD, yet despite this, patients often experience repeated chest infections.
<b>Objective:</b> We investigated the impact of preexisting COPD and its subtypes, chronic bronchitis and emphysema, on overall survival among Medicare enrollees diagnosed with non-small-cell lung cancer (NSCLC).
<b>Objectives:</b> The bronchodilator efficacy of a once-daily fixed-dose combination of tiotropium/formoterol (18/12 µg administered via a dry-powder inhaler, Discair) [TIO/FORM<sub>fixed</sub> group] vs a single-dose of tiotropium (18 µg) by Handihaler<sup>1</sup> alone [TIO<sub>mono</sub> group], or combined with formoterol 12 µg twice-daily by Aerolizer<sup>2</sup> [TIO/FORM<sub>bid</sub> group] was compared in patients with moderate-to-severe stable COPD.<b>Methods:</b> COPD patients were randomized (28 patients/group) to receive TIO/FORM<sub>fixed</sub>, TIO<sub>mono</sub><b>
<b>Patients and methods:</b> The data of 18 patients with OLD (16 with COPD, two with asthma COPD overlap), 11 with ILD, and 24 healthy volunteers, whose respiratory impedance was measured using a MostGraph-01 and other pulmonary functions including Cst and lung resistance (R<sub>L</sub>) were measured on the same day and were retrospectively collected and compared.
<b>Patients and methods:</b> The data of 18 patients with OLD (16 with COPD, two with asthma COPD overlap), 11 with ILD, and 24 healthy volunteers, whose respiratory impedance was measured using a MostGraph-01 and other pulmonary functions including Cst and lung resistance (R<sub>L</sub>) were measured on the same day and were retrospectively collected and compared.
<b>Results</b> Preoperative data were similar regarding age (62.78 ± 9.96 vs. 62.98 ± 9.66 years; <i>p</i> = 0.734), female sex (17.5 vs. 18.6%; <i>p</i> = 0.631), diabetes mellitus (26.3 vs. 27.2%; <i>p</i> = 0.74), EuroSCORE (3.21 ± 2.23 vs. 3.18 ± 2.41; <i>p</i> = 0.968), and COPD (16 vs. 16%; <i>p</i> = 1).
<i>Methods:</i> This was a cross-sectional survey study of adults using inhaled controllers intended for BID dosing for treatment of asthma and/or COPD.
<i>Methods:</i> We retrospectively compared the effect of an ambulatory PR program in nonsmoking patients with severe asthma and airway obstruction (FEV1/FVC ratio <70% and FEV1 < 80% measured twice, not under an exacerbation) and sex-, age-, FEV1-, and BMI-matched COPD controls.
<i>Objective.</i> In China, the Chinese medicine formula modified zhisou powder (MZP) is commonly used to treat COPD with cold-dryness syndrome (CDSCOPD) to relieve cough and sputum.